Treatment of results Sample Clauses

Treatment of results. (i) If Procedure 1 or 2 were employed in making concentration measurements, use a linear regression analysis with Equation 4 under para- graph (a)(2)(v)(B) of this section to cal- culate kh at 25 °C for each pH employed in the hydrolysis experiments. Cal- culate the coefficient of determination (R2) for each rate constant. Use Equa- tion 3 under paragraph (a)(2)(v)(B) of this section to calculate the hydrolysis half-life using kh.
Sample 1Sample 2Sample 3See All (8)
AutoNDA by SimpleDocs
Treatment of results. (i) The molar absorption co- efficient e should be calculated for all absorbance maxima of the test sub- stance. The formula for this calcula- tion is: ε= A , c,i ×d where the quantities are as defined above (see Definitions and units).
Sample 1Sample 2Sample 3See All (7)
Treatment of results. D a t a s h a ll be s u mm a r ized i n t a b u l a r fo r m .
Sample 1Sample 2
Treatment of results. ( i) If P r oced ur e 1 o r 2 we r e e m plo y ed i n m a k i n g co n ce n t r a t io n m e a s ur e m e n t s, u se a li n e a r r eg r essio n a n a l y s i s wi t h E q u a t io n 4 un de r p a r a- g r a p h ( a)(2)(v)(B) of t h i s sec t io n t o c a l- c u l a t e kh a t 25 °C fo r e a c h p H e m plo y ed i n t h e hy d r ol y s i s expe r i m e n t s. Ca l- c u l a t e t h e coefficie n t of de t e r m i n a t io n ( R2) fo r e a c h r a t e co n s t a n t . Use E q u a- t io n 3 un de r p a r a g r a p h ( a)(2)(v)(B) of t h i s sec t io n t o c a lc u l a t e t h e hy d r ol y s i s h a lf- life u s i n g kh.
Sample 1Sample 2
Treatment of results. ( i) T h e m ol a r a bso r p t io n co- efficie n t ε s h o u ld be c a lc u l a t ed fo r a ll a bso r b a n ce m a xi m a of t h e t es t s u b- s t a n ce. T h e fo r m u l a fo r t h i s c a lc u l a- t io n i s: ε = A , c,i ×d w h e r e t h e q u a n t i t ies a r e a s defi n ed a bove ( see Defi n i t io n s a n d un i t s).
Sample 1
Treatment of results. ( i) T es t co m po un d (10 m g c a r - bo n) i s t h eo r e t ic a ll y co n ve r t ed t o 0.833 mm ol CO 2. Abso r bed CO2 p r ecipi t a t es a s B a CO3 f r o m B a(OH)2, c a u s i n g a r e- d u c t io n i n a l k a li n i t y b y t h e eq u iv a le n t of 16.67 m L of 0.1 N HCl fo r co m ple t e co n ve r s io n of t h e t es t co m po un d c a r - bo n t o CO2. T h e r efo r e, t h e pe r ce n t t h e- o r e t ic a l CO2 evolved f r o m t h e t es t co m - po un d i s c a lc u l a t ed a t a ny s a m pli n g t i m e f r o m t h e fo r m u l a : P e r ce n t CO2 evol u t io n =[( T F–C F )/16.67] 100 (fo r 10 m g/L t es t co m po un d c a r bo n) w h e r e: T F = m L 0.1 N HCl r eq u i r ed t o t i t r a t e B a(OH)2 s a m ples f r o m t h e t es t fl a s k C F = m L 0.1 N HCl r eq u i r ed t o t i t r a t e B a(OH)2 s a m ples f r o m t h e co n t r ol fl a s k . ( ii) T h e c u m u l a t ive pe r ce n t CO2 evo- l u t io n a t a ny s a m ple t i m e i s c a lc u l a t ed a s t h e s u mm a t io n of t h e pe r ce n t CO2 evolved a t a ll s a m ple poi n t s of t h e t es t . ( iii) T h e pe r ce n t DOC dis a ppe a r a n ce f r o m t h e t es t co m po un d i s c a lc u l a t ed f r o m t h e followi n g eq u a t io n: P e r ce n t DOC R e m ov a l=[1¥( D T Fx¥ DC Fx)/( D T Fo¥ DC Fo)] 100 w h e r e: D T F = Dissolved o r g a n ic c a r bo n f r o m t es t fl a s k DC F = Dissolved o r g a n ic c a r bo n f r o m co n t r ol fl a s k o= D a y ze r o m e a s ur e m e n t s x= D a y of m e a s ur e m e n t s d ur i n g t es t .
Sample 1
Treatment of results. (i) Test compound (10 mg car- bon) is theoretically converted to 0.833 mmol CO2. Absorbed CO2 precipitates as BaCO3 from Ba(OH)2, causing a re- duction in alkalinity by the equivalent of 16.67 mL of 0.1 N HCl for complete conversion of the test compound car- bon to CO2. Therefore, the percent the- oretical CO2 evolved from the test com- pound is calculated at any sampling time from the formula: Percent CO2 evolution=[(TF¥CF)/16.67] 100 (for 10 mg/L test compound car- bon) where: TF= mL 0.1 N HCl required to titrate Ba(OH)2 samples from the test flask CF= mL 0.1 N HCl required to titrate Ba(OH)2 samples from the control flask.
Sample 1
AutoNDA by SimpleDocs
Treatment of results. (i) Test compound (10 mg car- where: DTF= Dissolved organic carbon from test flask DCF= Dissolved organic carbon from control flask o= Day zero measurements x= Day of measurements during test.
Sample 1
Treatment of results. (i) The molar absorption co- efficient e should be calculated for all
Sample 1

Related to Treatment of results

  • Notification of Results Within 10 days after satisfactory inspection and/or testing of Interconnection Facilities built by the Interconnection Customer (including, if applicable, inspection and/or testing after correction of defects or failures), the Interconnected Transmission Owner shall confirm in writing to the Interconnection Customer and Transmission Provider that the successfully inspected and tested facilities are acceptable for energization.

  • Publication of Results The National Aeronautics and Space Act (51 U.S.C. § 20112) requires NASA to provide for the widest practicable and appropriate dissemination of information concerning its activities and the results thereof. As such, NASA may publish unclassified and non-Proprietary Data resulting from work performed under this Agreement. The Parties will coordinate publication of results allowing a reasonable time to review and comment.

  • Interpretation of results 2.1.3.1. In the case of all vehicles except those of categories M3, N2 and N3, the time t shall not exceed 20 seconds.

  • Ownership of Results Any interest of Contractor or its subcontractors, in the Deliverables, including any drawings, plans, specifications, blueprints, studies, reports, memoranda, computation sheets, computer files and media or other documents prepared by Contractor or its subcontractors for the purposes of this Agreement, shall become the property of and will be transmitted to City. However, unless expressly prohibited elsewhere in this Agreement, Contractor may retain and use copies for reference and as documentation of its experience and capabilities.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Treatment The Asset Representations Reviewer agrees to hold and treat Confidential Information given to it under this Agreement in confidence and under the terms and conditions of this Section 4.08, and will implement and maintain safeguards to further assure the confidentiality of the Confidential Information. The Confidential Information will not, without the prior consent of the Issuer and the Servicer, be disclosed or used by the Asset Representations Reviewer, or its officers, directors, employees, agents, representatives or affiliates, including legal counsel (collectively, the “Information Recipients”) other than for the purposes of performing Reviews of Review Receivables or performing its obligations under this Agreement. The Asset Representations Reviewer agrees that it will not, and will cause its Affiliates to not (i) purchase or sell securities issued by the Seller or its Affiliates or special purpose entities on the basis of Confidential Information or (ii) use the Confidential Information for the preparation of research reports, newsletters or other publications or similar communications.

  • Transfer of Results 8.2.1 Each Party may transfer ownership of its own Results following the procedures of the Grant Agreement Article 30.

  • Allocation of Resources So that the mutually agreed­upon objectives of the agreement can be adequately met, resources from the School Board and the DJJ will be allocated based on the previously identified roles and responsibilities of each agency. XXX agrees to the following:

  • Determination of Responsiveness 28.1 The Procuring Entity's determination of a Tender's responsiveness is to be based on the contents of the Tender itself, as defined in ITT28.2.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

Time is Money Join Law Insider Premium to draft better contracts faster.